↓ Skip to main content

Dove Medical Press

Article Metrics

Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, December 2013
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
45 Mendeley
Title
Hospital readmissions following initiation of nebulized arformoterol tartrate or nebulized short-acting beta-agonists among inpatients treated for COPD
Published in
International Journal of Chronic Obstructive Pulmonary Disease, December 2013
DOI 10.2147/copd.s52557
Pubmed ID
Authors

Vamsi Bollu, Frank Ernst, John Karafilidis, Krithika Rajagopalan, Scott Robinson, Sidney Braman

Abstract

Inpatient admissions for chronic obstructive pulmonary disease (COPD) represent a significant economic burden, accounting for over half of direct medical costs. Reducing 30-day readmissions could save health care resources while improving patient care. Recently, the Patient Protection and Affordable Care Act authorized reduced Medicare payments to hospitals with excess readmissions for acute myocardial infarction, heart failure, and pneumonia. Starting in October 2014, hospitals will also be penalized for excess COPD readmissions. This retrospective database study investigated whether use of arformoterol, a nebulized long-acting beta agonist, during an inpatient admission, had different 30-day all-cause readmission rates compared with treatment using nebulized short-acting beta agonists (SABAs, albuterol, or levalbuterol).

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 2%
Unknown 44 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 20%
Student > Master 7 16%
Other 6 13%
Student > Bachelor 5 11%
Student > Doctoral Student 4 9%
Other 12 27%
Unknown 2 4%
Readers by discipline Count As %
Medicine and Dentistry 24 53%
Nursing and Health Professions 7 16%
Pharmacology, Toxicology and Pharmaceutical Science 3 7%
Economics, Econometrics and Finance 3 7%
Agricultural and Biological Sciences 2 4%
Other 4 9%
Unknown 2 4%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2013.
All research outputs
#3,064,800
of 4,507,509 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#322
of 479 outputs
Outputs of similar age
#79,753
of 122,045 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#29
of 46 outputs
Altmetric has tracked 4,507,509 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 479 research outputs from this source. They receive a mean Attention Score of 2.3. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 122,045 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.